ACADIA Pharmaceuticals (ACAD) Receives a Buy From RBC Capital

TipRanksJan 10 09:49 · Ratings

Mizuho Securities Maintains ACADIA Pharmaceuticals(ACAD.US) With Hold Rating, Announces Target Price $20

Futu NewsJan 9 19:34 · Ratings

Analysts Conflicted on These Healthcare Names: Avadel Pharmaceuticals (AVDL) and ACADIA Pharmaceuticals (ACAD)

TipRanksJan 9 19:30 · Ratings

Further Weakness as ACADIA Pharmaceuticals (NASDAQ:ACAD) Drops 5.2% This Week, Taking Five-year Losses to 61%

Yahoo FinanceJan 9 03:58

ACADIA Pharmaceuticals Analyst Ratings

BenzingaJan 3 23:58 · Ratings

Guggenheim Downgrades ACADIA Pharmaceuticals(ACAD.US) to Hold Rating, Announces Target Price $20

Futu NewsJan 3 19:31 · Ratings